# Jenburkt Pharmaceuticals Ltd (JENBURPH)
> Exchange: NSE | Sector: Pharma | ISIN: 

## Price
Current Price: ₹1168
Day Change: +1.22%
52W High: ₹1410
52W Low: ₹944
Market Cap: ₹529 Cr

## Valuation
P/E: 16.34
P/B: 2.89
EPS: ₹73.42
Book Value: ₹414.4
Dividend Yield: 168%

## Returns
1Y Return: 13.93%

## Profitability
ROE: 19.28%
ROCE: 0%
Debt/Equity: 0
Revenue Growth: 0%
Profit Growth: 0%
EBITDA Margin: 0%
Operating Margin: 0%

## About
Jenburkt Pharmaceuticals Ltd is a Drug Manufacturers - Specialty & Generic company listed on BSE. The page combines exchange quotes, financial statements, shareholding, filings, and news so investors can review the business in one place.
Sector: Pharma
Industry: Drug Manufacturers - Specialty & Generic
Sub Industry: Unknown

## Business Model
Overview: Jenburkt Pharmaceuticals Ltd makes money through Domestic formulations, Exports and regulated markets, Specialty or institutional sales in Drug Manufacturers - Specialty & Generic. Revenue quality depends on demand growth, margin discipline, balance-sheet strength, and the company's ability to defend its position within Pharma.
Source: Derived from stock data
Revenue Streams:
- Domestic formulations
- Exports and regulated markets
- Specialty or institutional sales
Operating Model:
- Develops, manufactures, distributes, or services healthcare products across regulated channels.
- Approvals, product mix, compliance quality, and R&D productivity shape growth.
Recent Context:
- Announcement: Compliances-Reg.24(A)-Annual Secretarial Compliance
- Announcement: Intimation Of Record Date And Cut-Off Date
- BSE Filing: Compliances-Reg.24(A)-Annual Secretarial Compliance

## Access
Current tier: anonymous
More history: Register free to see 8 more years.

## Data Freshness
Quote Updated: 2026-05-25T05:30:20.071Z
Price History Updated: 2026-05-25T05:30:21.307Z
Latest Price History Date: 2026-05-25
Technicals Updated: 2026-05-25T05:30:21.307Z
Quant Updated: 2026-05-25T05:30:21.307Z
Sentiment Updated: 2026-05-25T05:30:21.307Z
Financials Status: current
Financials Updated: 2026-05-18T11:30:01.208Z
Financials Last Attempt: 2026-05-18T11:30:01.208Z
Financials Provider Tried: database
Latest P&L Period: FY 2025
Latest Balance Sheet Period: FY 2025
Latest Cash Flow Period: FY 2025

## P&L (Mar 2016)
Revenue: ₹85 Cr
Operating Profit: ₹15 Cr (OPM 18%)
Net Profit: ₹10 Cr
Tax: ₹14 Cr

## Annual P&L History
Mar 2016: Rev ₹85Cr | PAT ₹10Cr | OPM 18%
Mar 2017: Rev ₹94Cr | PAT ₹11Cr | OPM 18%
Mar 2018: Rev ₹103Cr | PAT ₹14Cr | OPM 19%

## Balance Sheet (Mar 2016)
Total Assets: ₹61 Cr
Total Liabilities: ₹61 Cr
Borrowings: ₹7 Cr
Cash: ₹undefined Cr

## Shareholding
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%

---
Source: rupiya.io/stocks/jenburph
Disclaimer: For research and education only. Not investment advice.